Larvol Delta - Arugula-Sciences-announces-FDA-Approval-to-Proceed-with-Phase-1-Study-of-SIG002-a-Perinatalderived-Secretome-Product-for-the-Treatment-of-Big-Toe-Osteoarthritis-Hallux-Rigidus

SIG002 - Arugula Sci

https://www.businesswire.com/news/home/20230131005123/en/Arugula-Sciences-announces-FDA-Approval-to-Proceed-with-Phase-1-Study-of-SIG002-a-Perinatal-derived-Secretome-Product-for-the-Treatment-of-Big-Toe-Osteoarthritis-Hallux-Rigidus

Jan 31, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next